Trade ProShares Ultra Nasdaq Biotechnology - BIB CFD
Add to favourite- Summary
- Historical Data
- Events
- Ownership
Spread | 0.13 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004012% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 45.24 |
Open* | 44.56 |
1-Year Change* | -27.93% |
Day's Range* | 44.56 - 46.43 |
52 wk Range | N/A |
Average Volume (10 days) | N/A |
Average Volume (3 months) | N/A |
Market Cap | N/A |
P/E Ratio | N/A |
Shares Outstanding | N/A |
Revenue | N/A |
EPS | N/A |
Dividend (Yield %) | N/A |
Beta | N/A |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 1, 2023 | 46.43 | 1.48 | 3.29% | 44.95 | 46.43 | 44.50 |
Nov 30, 2023 | 45.24 | 0.80 | 1.80% | 44.44 | 45.88 | 44.44 |
Nov 29, 2023 | 43.94 | 0.74 | 1.71% | 43.20 | 44.51 | 43.20 |
Nov 28, 2023 | 43.15 | 0.18 | 0.42% | 42.97 | 43.25 | 42.54 |
Nov 27, 2023 | 43.48 | -0.12 | -0.28% | 43.60 | 43.67 | 42.95 |
Nov 24, 2023 | 43.83 | 0.31 | 0.71% | 43.52 | 44.37 | 43.52 |
Nov 22, 2023 | 43.54 | 0.26 | 0.60% | 43.28 | 43.89 | 43.03 |
Nov 21, 2023 | 43.05 | -0.48 | -1.10% | 43.53 | 43.67 | 43.02 |
Nov 20, 2023 | 44.02 | 0.92 | 2.13% | 43.10 | 44.35 | 43.06 |
Nov 17, 2023 | 43.48 | 0.80 | 1.87% | 42.68 | 43.57 | 42.52 |
Nov 16, 2023 | 42.49 | -0.78 | -1.80% | 43.27 | 43.42 | 42.21 |
Nov 15, 2023 | 43.30 | 0.20 | 0.46% | 43.10 | 44.39 | 43.05 |
Nov 14, 2023 | 43.48 | 0.47 | 1.09% | 43.01 | 43.88 | 43.01 |
Nov 13, 2023 | 41.79 | 0.38 | 0.92% | 41.41 | 41.79 | 40.46 |
Nov 10, 2023 | 41.75 | 0.39 | 0.94% | 41.36 | 41.89 | 40.31 |
Nov 9, 2023 | 41.46 | -2.62 | -5.94% | 44.08 | 44.17 | 41.34 |
Nov 8, 2023 | 44.17 | -0.93 | -2.06% | 45.10 | 45.13 | 43.64 |
Nov 7, 2023 | 45.65 | 0.70 | 1.56% | 44.95 | 45.73 | 44.41 |
Nov 6, 2023 | 45.23 | -0.81 | -1.76% | 46.04 | 46.15 | 45.01 |
Nov 3, 2023 | 45.67 | 1.17 | 2.63% | 44.50 | 46.14 | 44.50 |
ProShares Ultra Nasdaq Biotechnology Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ProShares Ultra Nasdaq Biotechnology Company profile
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. This ETF offers 2x daily long leverage to the broad-based NASDAQ Biotechnology Index, making it a powerful tool for investors with a bullish short-term outlook for biotechnology or pharmaceuticals companies. Investors should note that BIB’s leverage resets on a daily basis, which results in compounding of returns when held for multiple periods.US
News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com